NeOnc adds director after Chiang resignation

NeOnc Technologies Holdings, Inc. reported a change on its Board of Directors.

(Moderate)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

NeOnc Technologies Holdings, Inc. reported a change on its Board of Directors. On June 27, 2026, Class II director Ming-Fu (Alan) Chiang, M.D., Ph.D., MBA, resigned from the Board and from the Scientific Advisory Board, and the company states his resignation was not due to any disagreement over operations, policies, or practices.

On July 1, 2026, the Board elected Nasim Shomali as a Class II director to serve until the 2027 annual meeting of stockholders. She previously served as a Strategy Executive at Accenture from April 2013 to April 2026, advising large companies on enterprise strategy and transformation. The company notes there is no arrangement under which she was selected, and discloses that Shomali is the niece of President, Chief Executive Officer and Executive Chairman Amir Heshmatpour.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Key Figures

Chiang resignation date: June 27, 2026 Shomali election date: July 1, 2026 Term end reference: 2027 annual meeting +1 more

4 metrics

Chiang resignation date June 27, 2026 Effective date of director and Scientific Advisory Board resignation

Shomali election date July 1, 2026 Effective date of Nasim Shomali’s appointment as Class II director

Term end reference 2027 annual meeting End of current term for Shomali as Class II director

Accenture tenure period April 2013–April 2026 Duration of Shomali’s Strategy Executive role at Accenture

Key Terms

Class II director, Scientific Advisory Board, Emerging growth company, annual meeting of stockholders

4 terms

Class II director financial

"a Class II director, notified NeOnc Technologies Holdings, Inc."

A class II director is a member of a company’s board who belongs to one of several staggered groups of directors, each group standing for election in different years. For investors, this matters because staggered terms slow wholesale board turnover—like rotating members of a neighborhood committee—making sudden changes in control or strategy harder and affecting how quickly shareholders can influence corporate direction.

Scientific Advisory Board financial

"In connection with his resignation, Dr. Chiang also resigned from the Company’s Scientific Advisory Board."

A scientific advisory board is a group of independent experts—often scientists, clinicians or technical specialists—who give a company guidance on its research, product development and regulatory strategy. For investors, their role is like an external quality check: credible experts can reduce technical risk, improve the chance of regulatory approval or successful products, and boost confidence that management’s science claims are realistic and well-directed.

Emerging growth company regulatory

"Emerging growth company On June 27, 2026, Ming-Fu"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

annual meeting of stockholders financial

"to serve as a Class II director until the Company’s 2027 annual meeting of stockholders."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What board change did NeOnc Technologies (NTHI) disclose?

NeOnc Technologies reported that Class II director Ming-Fu (Alan) Chiang resigned from the Board and Scientific Advisory Board, effective June 27, 2026. The company stated his departure was not due to any disagreement regarding operations, policies, or practices.

Who replaced Dr. Chiang on NeOnc Technologies' board?

The Board elected Nasim Shomali as a Class II director effective July 1, 2026, to serve until the 2027 annual meeting. She brings extensive strategy experience from her role as a Strategy Executive at Accenture between April 2013 and April 2026.

What is Nasim Shomali’s professional background before joining NTHI’s board?

From April 2013 to April 2026, Nasim Shomali served as a Strategy Executive at Accenture. She advised Fortune 20 executives on enterprise strategy, operating-model development, product redesign, market expansion, and efficiency initiatives across global software, platform, technology, and sustainability portfolios.

Does the new NeOnc director have any relationship with company leadership?

Yes. The filing states that new director Nasim Shomali is the niece of Amir Heshmatpour, who serves as NeOnc’s President, Chief Executive Officer and Executive Chairman. The company also notes there was no arrangement or understanding under which she was selected.

How long will Nasim Shomali serve on NeOnc Technologies' board?

Nasim Shomali was elected as a Class II director and will serve until NeOnc Technologies’ 2027 annual meeting of stockholders. Her future service beyond that meeting would depend on re-election by stockholders at that time, consistent with standard board classification.

Did NeOnc indicate any disputes behind Dr. Chiang’s resignation?

The company explicitly stated that Dr. Ming-Fu (Alan) Chiang’s resignation from the Board and Scientific Advisory Board was not the result of a disagreement with NeOnc on any matter relating to its operations, policies, or practices, suggesting an orderly transition rather than a conflict.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 07/02/2026 - 05:11 PM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported):

June 27, 2026

NEONC TECHNOLOGIES HOLDINGS, INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

001-42567		92-1954864
(Commission File Number)		(IRS Employer Identification No.)

23975 Park Sorrento, Suite 205 Calabasas, CA		91302
(Address of Principal Executive Offices)		(Zip Code)

(818) 570-6844

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbols		Name of each exchange on which registered
Common Stock, par value $0.0001		NTHI		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 27, 2026, Ming-Fu (Alan) Chiang, M.D., Ph.D., MBA, a Class II director, notified NeOnc Technologies Holdings, Inc. (the “Company”) of his resignation as a member of the Company’s Board of Directors (the “Board”), effective immediately. In connection with his resignation, Dr. Chiang also resigned from the Company’s Scientific Advisory Board. Dr. Chiang’s resignation was not the result of a disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.

On July 1, 2026, the Board of the Company elected Nasim Shomali as a director of the Company, effective immediately, to serve as a Class II director until the Company’s 2027 annual meeting of stockholders.

From April 2013 to April 2026, Ms. Shomali served as a Strategy Executive at Accenture. In this capacity, she advised senior executives at Fortune 20 companies on enterprise strategy, operating-model development, and large-scale transformation initiatives. Her work included leading corporate strategy programs, supporting product redesign and new-product introduction, guiding market-expansion strategies, and developing automation and efficiency roadmaps across global business units. She also managed and expanded Accenture’s U.S. Software, Platform, and Technology sustainability portfolio. Ms. Shomali earned her M.B.A., with a concentration in finance, from the UCLA Anderson School of Management. She holds dual bachelor’s degrees in Bioengineering and Mathematics from the University of Washington and completed the Sustainable Leadership Development Executive Program at the Yale School of Management.

There is no arrangement or understanding between Ms. Shomali and any other person pursuant to which she was selected as director. Shomali is the niece of Amir Heshmatpour, the Company’s President, Chief Executive Officer and Executive Chairman.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: July 2, 2026	NeOnc Technologies Holdings, Inc.

	By:	/s/ Amir Heshmatpour
		Name:	Amir Heshmatpour
		Title:	Chief Executive Officer, President and Executive Chairman

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents